Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001064900-24-000001
Filing Date
2024-11-25
Accepted
2024-11-25 17:09:34
Documents
1
Period of Report
2024-11-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5624
  Complete submission text file 0001064900-24-000001.txt   7344
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O 225 LONG AVENUE HILLSIDE NJ 07205
Business Address
RIVA SHEPPARD (Reporting) CIK: 0001064900 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31668 | Film No.: 241496974